← FDA DRUG APPROVALS

FDA ANDA · ANDA203929

DOXERCALCIFEROL

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA203929
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-07
LATEST ACTION
2025-03-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOXERCALCIFEROLDiscontinued
DOXERCALCIFEROL 2MCG/ML (2MCG/ML) · INJECTABLE · INJECTION
DOXERCALCIFEROLDiscontinued
DOXERCALCIFEROL 4MCG/2ML (2MCG/ML) · INJECTABLE · INJECTION

Approval history

2025-03-14Labeling · Supplement 8 · standardAP
2016-10-13Labeling · Supplement 4 · standardAP
2015-05-07UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →